Ivonescimab (20mg/kg Q3W): clinical trials recruiting now
Fewer than 3 recruiting trials found.
2
Recruiting trials
15
Conditions studied
24
US states with sites
2
Countries
Phase breakdown
Phase 2 2
Conditions being studied
Recruiting trials involving Ivonescimab (20mg/kg Q3W)
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- SCRT Followed by AK112 in pMMR/MSS Mid-low Rectal Cancer
Common questions
How many recruiting trials involve Ivonescimab (20mg/kg Q3W)?
2 recruiting trials across 15 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.